What's Going On With Vanda Pharmaceuticals Shares Today?
What's Going On With Vanda Pharmaceuticals Shares Today?
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading lower after Future Pak withdrew its proposal to purchase the company.
万达生物制药股份有限公司（纳斯达克:VNDA）股价下跌，因未来派克撤回了其购买公司的提议。
"Consistent with the position indicated in its June 13, 2024 letter to Vanda Pharmaceuticals, Future Pak LLC and its affiliates today announced that it is withdrawing its offer to acquire the company, effective immediately, and will focus on other strategic objectives," according to a statement.
根据一份声明：“与其2024年6月13日写给万达生物制药的回应中表明的立场一致，未来派克及其附属公司今天宣布立即撤回其购买公司的提议，并专注于其他战略目标。”
This decision follows Vanda's ongoing lack of response and their rejection of Future Pak's final proposal.
这一决定是基于万达一直未回应未来派克并拒绝其最终提议。
According to Benzinga Pro, VNDA stock has lost over 9% in the past year. Investors can gain exposure to the stock via Invesco NASDAQ Future Gen 200 ETF (NASDAQ:QQQS).
据Benzinga Pro报道，VNDA股票在过去一年中下跌了超过9%。投资者可以通过景顺纳斯达克未来200 ETF（纳斯达克:QQQS）获得股票曝光。
In a recent press release, Vanda mentioned that the takeover proposals from Future Pak and Cycle Group substantially undervalued the company.
在最近的新闻发布中，万达提到未来派克和赛科集团的收购提议大大低估了公司。
Vanda highlighted that the unsolicited proposal from Cycle Group for $8.00 per share and the revised unsolicited proposal from Future Pak to acquire Vanda for $8.50-$9.00 per share are not in the best interests of the company and its shareholders. "Accordingly, the Board has rejected the proposals," the company said then.
万达强调，赛科集团以每股8.00美元的非约请性提议和未来派克修改后的提议以每股8.50-9.00美元的价格收购万达股份并不符合公司及其股东的最佳利益。公司表示：“因此，董事会已经拒绝了这些提议。”
Earlier in April, Vanda rejected Future Pak's $7.25 – $7.75 per share offer, saying it significantly undervalued the company.
4月份早些时候，万达拒绝了未来派克每股7.25-7.75美元的收购提议，称其大大低估了公司。
In April, the FDA approved Vanda Pharmaceuticals' Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
今年4月，美国FDA批准了万达制药的Fanapt（iloperidone）片剂，用于治疗成人双相I型障碍相关的急性躁狂或混合发作。
Price Action: VNDA shares are trading lower by 1.92% to $5.865 at last check Thursday.
价格走势：VNDA股价周四最后查询下跌了1.92％至5.865美元。
Photo via Shutterstock
图片来自shutterstock。